Form 990 for tax year 2023

Totals

Total revenue

$1,246,687

Total expenses

$1,171,436

Contributions and grants received

$1,247,340

Grants paid

$0

Program service revenue

$0

Investment income

-$653

Other revenue

$0

Total assets, end of year

$517,762

Total liabilities, end of year

$90,912

Net assets or fund balances, end of year

$426,850

Program services expenses (Part IX)

$913,622

Management and general expenses

$128,902

Fundraising expenses

$128,912

Program service expenses (Part III)

$913,622

Program services were 78.0% of total expenses calculated — Part IX's program-services column over total expenses, both as filed.

Line items

Every line the filer filed in Parts VIII, IX and X, as filed and in filed order. Blank columns are left out, and the lines are not forced to add up to the totals above.

Mission and programs · 2023

• PATIENT NAVIGATION AND SUPPORT:CANCER COMMONS HELPS PATIENTS UNDERSTAND THEIR DIAGNOSIS AND IDENTIFY THEIR BEST TREATMENT OPTIONS, COMBINING COMPASSION WITH DEEP SCIENTIFIC KNOWLEDGE.PROVIDED PERSONALIZED GUIDANCE TO MORE THAN 1,100 PATIENTS AND CAREGIVERS IN FY2024, ASSISTED INDIVIDUALS WITH OVER 35 DIFFERENT CANCER TYPES. MANY SOUGHT SUPPORT FOR ADVANCED, HARD-TO-TREAT CANCERS, INCLUDING MORE THAN 300 WITH BRAIN CANCER AND NEARLY 150 WITH PANCREATIC CANCER.PATIENT NAVIGATORS FACILITATE REGISTRATION, ASSIST IN IDENTIFYING TREATMENT GOALS, AND COLLECT MEDICAL RECORDS TO STREAMLINE ACCESS TO EXPERT GUIDANCE AND VIABLE TREATMENT OPTIONS.ADDITIONAL SERVICES:. COMPREHENSIVE TREATMENT REVIEWS - CONDUCTS IN-DEPTH TREATMENT REVIEWS TAILORED TO EACH PATIENT'S NEEDS, WHICH MAY INCLUDE ASSESSMENTS OF CLINICAL TRIAL ELIGIBILITY OR RECOMMENDATIONS FOR OFF-LABEL TREATMENT OPTIONS. ALL GUIDANCE IS GROUNDED IN THE LATEST RESEARCH, BEST PRACTICES, AND MEDICAL DATA.. PRECISION ONCOLOGY EXPERTISE - ANALYZES DATA FROM CUTTING-EDGE MOLECULAR PROFILING, LIQUID BIOPSY, AND FUNCTIONAL PRECISION MEDICINE DRUG SCREENING. THEIR STAFF SCIENTISTS AND EXTERNAL EXPERTS USE THIS INFORMATION TO RECOMMEND TARGETED THERAPIES WITH THE HIGHEST POTENTIAL FOR SUCCESS.. ONGOING SUPPORT THE TEAM REMAINS COMMITTED TO PATIENTS BEYOND THE INITIAL RECOMMENDATIONS. THE ORGANIZATION PROVIDES PERIODIC REVIEWS AND UPDATES, ACCOUNTING FOR CHANGES IN DISEASE STATUS, EMERGING RESEARCH, AND NEWLY AVAILABLE TREATMENTS. THEIR TEAM CONTINUES TO ENGAGE WITH PATIENTS, ADAPTING CARE PLANS THROUGHOUT EACH PATIENT'S JOURNEY TO ACHIEVE OPTIMAL OUTCOMES.

  Expenses $792,502

• PARTNERSHIPS:CANCER COMMONS COLLABORATES WITH ORGANIZATIONS THAT SHARE ITS PATIENT-FOCUSED APPROACH TO CANCER CARE. THROUGH A PARTNERSHIP WITH XCURES, CANCER COMMONS PATIENTS ARE INVITED TO ENROLL IN XCELSIOR, A PLATFORM TRIAL THAT INTEGRATES PRECISION ONCOLOGY INSIGHTS WITH CUTTINGEDGE TECHNOLOGY TO OFFER INNOVATIVE TREATMENT OPPORTUNITIES.CANCER COMMONS ALSO MAINTAINS PARTNERSHIPS WITH INSTITUTIONS AND ORGANIZATIONS SUPPORTING PATIENTS WITH COMPLEX CANCER CASES. THESE ENTITIES EITHER REFER PATIENTS NEEDING EXPERT GUIDANCE OR PROVIDE SPECIALIZED SERVICES DIRECTLY. KEY PARTNERSHIPS IN FY2024 INCLUDED THE MUSELLA FOUNDATION FOR BRAIN TUMOR RESEARCH & INFORMATION AND HEAD FOR THE CURE.

  Expenses $91,590

• LEARNING HEALTH SYSTEM DEVELOPMENT:CANCER COMMONS DEVELOPED A PROTOTYPE LEARNING HEALTH SYSTEM (LHS) SOFTWARE AIMED AT ADVANCING TREATMENT RECOMMENDATIONS THROUGH TECHNOLOGY. THE SYSTEM IS DESIGNED TO COMBINE REAL-WORLD PATIENT DATA AND AI ANALYSIS TO HELP REFINE DECISION-MAKING AND ASSIST ONCOLOGISTS IN IDENTIFYING OPTIMAL TREATMENT OPTIONS FOR PATIENTS WITH ADVANCED CANCERS.THIS DEMO VERSION OF THE LHS WAS DESIGNED TO PROCESS AND ANALYZE PATIENT CASES, ASSESSING ITS POTENTIAL TO SPEED UP DECISION-MAKING AND PROVIDE ONCOLOGISTS WITH USEFUL, DATA-DRIVEN INSIGHTS. THESE EFFORTS LAY THE FOUNDATION FOR A MORE EFFICIENT CASE REVIEW PROCESS WITH THE GOAL OF EXPANDING CANCER COMMONS' ABILITY TO SUPPORT MORE PATIENTS AND CONTRIBUTE VALUABLE INSIGHTS TO CANCER RESEARCH AND CARE.

  Expenses $29,530

As filed on the 2023 return. The filer continues this part on Schedule O, which is not shown here.

Listed in Part VII

Compensation is as filed in Part VII: reportable pay from this organization and from related organizations, other compensation, and hours per week. The total, marked calculated, is our sum of the three dollar columns, with a blank column counted as $0; the form itself has no total. On a Form 990-EZ the columns are Part IV's instead, and on a Form 990-PF Part VIII's — compensation, contributions to benefit plans, and expense account — and the total sums those.

Grants on this return

No itemized grants to organizations on this return.

Provenance

Return type

form_990

Tax year

2023

Filed

9 May 2025

IRS schema version

2023v6.0

Source object

202531349349306983

Check it against the return as filed: the GivingTuesday Data Lake hosts a public copy of the original XML.

The source document this was parsed from is served over the API, which is where bulk and document access live.